Literature DB >> 24891329

Was the flu drug zanamivir a breakthrough or money for old rope?

Ray Moynihan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24891329     DOI： 10.1136/bmj.g3611

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews.

Authors:  Shai Mulinari; Courtney Davis
Journal:  Health Res Policy Syst       Date:  2017-11-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.